Showing results (321-330 of 379) with videos related to

Sort By:
Pageof 38
British Journal of Cancer|December 1, 1988
High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytomaE K Mbidde, P J Selby, T J Perren, et al.
Acta Psychiatrica Scandinavica|May 31, 2017
COMT Val158Met and MTHFR C677T moderate risk of schizophrenia in response to childhood adversityJ-C Debost, M Debost, J Grove, et al.
British Journal of Cancer|May 20, 2004
In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomographyH Barthel, H Wilson, D R Collingridge, et al.
Current Medicinal Chemistry|June 9, 2011
Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitorsS J Shuttleworth, F A Silva, A R L Cecil, et al.
RSC Chemical Biology|June 15, 2026
Stabilized thioamide peptide agonists of the neuropeptide Y type 2 receptor for targeted cancer imagingHoang Anh T Phan, Yanan Chang, Taylor M Barrett, et al.
Pediatric Radiology|November 12, 2015
Ultrasound-guided fine-needle aspiration biopsy of pediatric thyroid nodulesPranav Moudgil, Ranjith Vellody, Amer Heider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Cancer Research|August 1, 1997
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxiaE O Aboagye, R J Maxwell, A B Kelson, et al.
Investigative Ophthalmology & Visual Science|May 1, 1988
L-653,328: an ocular hypotensive agent with modest beta receptor blocking activityM F Sugrue, P Gautheron, J Grove, et al.
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
Pageof 38